- Home
- SGLY vs AEMD Comparison
SGLY vs AEMD Comparison
Compare SGLY & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$2.72
Company Overview
Basic Information| Metric | SGLY | AEMD |
|---|---|---|
| Founded | 2001 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4M | 3.4M |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | SGLY | AEMD |
|---|---|---|
| Price | $0.63 | $2.72 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $287.50 |
| AVG Volume (30 Days) | ★ 571.0K | 84.2K |
| Earning Date | 02-18-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,619,679.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.45 | $2.44 |
| 52 Week High | $5.49 | $84.40 |
Technical Indicators
Market Signals| Indicator | SGLY | AEMD |
|---|---|---|
| Relative Strength Index (RSI) | 55.47 | 40.96 |
| Support Level | $0.45 | $2.44 |
| Resistance Level | $0.67 | $2.98 |
| Average True Range (ATR) | 0.08 | 0.21 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 83.35 | 22.05 |
Price Performance
Historical Comparison SGLY
AEMD
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.